These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 9393559)

  • 1. The antifungal effect of lactoferrin and lysozyme on Candida krusei and Candida albicans.
    Samaranayake YH; Samaranayake LP; Wu PC; So M
    APMIS; 1997 Nov; 105(11):875-83. PubMed ID: 9393559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The fungicidal effect of human lactoferrin on Candida albicans and Candida krusei.
    Nikawa H; Samaranayake LP; Tenovuo J; Pang KM; Hamada T
    Arch Oral Biol; 1993 Dec; 38(12):1057-63. PubMed ID: 8141667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in vitro lysozyme susceptibility of Candida species cultured in sucrose supplemented media.
    Samaranayake YH; MacFarlane TW; Samaranayake LP; Aitchison TC
    Microbios; 1993; 74(298):23-8. PubMed ID: 8336552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Brief Exposure to Lysozyme and Lactoferrin on Pathogenic Attributes of Oral Candida.
    Ellepola ANB; Khan ZU
    Int Dent J; 2024 Oct; 74(5):1161-1167. PubMed ID: 38749888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifungal effects of lysozyme and lactoferrin against genetically similar, sequential Candida albicans isolates from a human immunodeficiency virus-infected southern Chinese cohort.
    Samaranayake YH; Samaranayake LP; Pow EH; Beena VT; Yeung KW
    J Clin Microbiol; 2001 Sep; 39(9):3296-302. PubMed ID: 11526166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated lactoferrin and fluconazole synergism against Candida albicans and Candida glabrata vaginal isolates.
    Naidu AS; Fowler RS; Martinez C; Chen J; Tulpinski J
    J Reprod Med; 2004 Oct; 49(10):800-7. PubMed ID: 15568403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic activity of lysozyme and antifungal agents against Candida albicans biofilms on denture acrylic surfaces.
    Samaranayake YH; Cheung BP; Parahitiyawa N; Seneviratne CJ; Yau JY; Yeung KW; Samaranayake LP
    Arch Oral Biol; 2009 Feb; 54(2):115-26. PubMed ID: 19038377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro susceptibility of oral Candida to seven antifungal agents.
    Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
    Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
    Krcmery V; Barnes AJ
    J Hosp Infect; 2002 Apr; 50(4):243-60. PubMed ID: 12014897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Candida species in different hospital wards and their susceptibility to antifungal agents: results of a three year survey.
    Fadda ME; Podda GS; Pisano MB; Deplano M; Cosentino S
    J Prev Med Hyg; 2008 Jun; 49(2):69-74. PubMed ID: 18847180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salivary lactoferrin in HIV-infected children: correlation with Candida albicans carriage, oral manifestations, HIV infection and its antifungal activity.
    Alves TP; Simões AC; Soares RM; Moreno DS; Portela MB; Castro GF
    Arch Oral Biol; 2014 Aug; 59(8):775-82. PubMed ID: 24837476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of lysozyme and lactoferrin on oral Candida isolates exposed to polyene antimycotics and fluconazole.
    Anil S; Samaranayake LP
    Oral Dis; 2002 Jul; 8(4):199-206. PubMed ID: 12206401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
    Sobel JD; Ohmit SE; Schuman P; Klein RS; Mayer K; Duerr A; Vazquez JA; Rampalo A;
    J Infect Dis; 2001 Jan; 183(2):286-93. PubMed ID: 11204125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Brief Exposure to Drugs with Antifungal Properties on the Susceptibility of Oral Candida dubliniensis Isolates to Lysozyme and Lactoferrin.
    Ellepola ANB; Dassanayake RS; Khan Z
    Med Princ Pract; 2018; 27(6):523-530. PubMed ID: 30173211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candida krusei fungaemia: antifungal susceptibility and clinical presentation of an uncommon entity during 15 years in a single general hospital.
    Muñoz P; Sánchez-Somolinos M; Alcalá L; Rodríguez-Créixems M; Peláez T; Bouza E
    J Antimicrob Chemother; 2005 Feb; 55(2):188-93. PubMed ID: 15650001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of antifungal agents on the in vitro susceptibility of Candida albicans to apo-lactoferrin.
    Nikawa H; Samaranayake LP; Tenovuo J; Hamada T
    Arch Oral Biol; 1994 Oct; 39(10):921-3. PubMed ID: 7741664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of salivary factors in persistent oral carriage of Candida in humans.
    Hibino K; Samaranayake LP; Hägg U; Wong RW; Lee W
    Arch Oral Biol; 2009 Jul; 54(7):678-83. PubMed ID: 19439266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the anti-Candida activity of apo-lactoferrin by dietary sucrose and tunicamycin in vitro.
    Nikawa H; Samaranayake LP; Hamada T
    Arch Oral Biol; 1995 Jun; 40(6):581-4. PubMed ID: 7677606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
    De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
    J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevalence of Candida albicans and Candida non-albicans in clinical samples during 1999-2001].
    Mujica MT; Finquelievich JL; Jewtuchowicz V; Iovannitti CA
    Rev Argent Microbiol; 2004; 36(3):107-12. PubMed ID: 15559191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.